| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/12/2008 | WO2008068424A2 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 06/12/2008 | WO2008068265A1 Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases |
| 06/12/2008 | WO2008068174A1 4,5,6,7-tetrahydro-thieno [2,3-c] pyridines as h3 modulators |
| 06/12/2008 | WO2008068173A1 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators |
| 06/12/2008 | WO2008067863A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 06/12/2008 | WO2008067756A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof |
| 06/12/2008 | WO2008067713A1 Compounds having substituted cyclopentane structure, their preparation methods and medical uses |
| 06/12/2008 | WO2008067712A1 Compounds having substituted cyclopropane structure, preparation method and uses thereof |
| 06/12/2008 | WO2008067711A1 Compounds having substituted 4-members ring structure and their medicine uses |
| 06/12/2008 | WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof |
| 06/12/2008 | WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof |
| 06/12/2008 | WO2008067639A1 Composition for promoting weight loss comprising yohimbine, evodia rutaecarpia extract and l-carnitine |
| 06/12/2008 | WO2008048084B1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure |
| 06/12/2008 | WO2008035305A3 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 06/12/2008 | WO2007142979A3 Use of gpr101 receptor in methods to identify modulators of hypothalamic proopiomelanocortin (pomc)-derived biologically active peptide secretion useful in the treatment of pomc-derived biologically active peptide-related disorders |
| 06/12/2008 | WO2007089548A3 Compounds and methods for modulating protein trafficking |
| 06/12/2008 | WO2007078726A3 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 06/12/2008 | US20080140450 Treatment of metabolic syndrome with norfluoxetine |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139664 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 06/12/2008 | US20080139663 Cycloalkylmethylamine analogs; use treating obesity or related co-morbid indications |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139628 Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial Agonists |
| 06/12/2008 | US20080139625 Pyrrolidin-2-One and Piperidin-2-One Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 06/12/2008 | US20080139624 Pellets; sustained release |
| 06/12/2008 | US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments |
| 06/12/2008 | US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation |
| 06/12/2008 | US20080139589 2-Methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone; sleep, psychological, nervous system, and attention deficit disorders; drug abuse, alcoholism; antidiabetic agents, cognition activators; Alzheimer's and Parkinson's disease; histamine H3 receptor antagonists |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139570 e.g. N-[2-(6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-3-oxo-4-hydropyridino[2,3-b]pyrazin-4-yl)ethyl]acetamide; antidiabetic agent; abnormal lipid levels, cardiovascular disease, obesity, oily skin conditions, metabolic syndrome |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139562 e.g. {-[3-Cyclopentyl-2-(4-methane sulfonyl-phenyl)-propionylamino]-5-methyl-thiazol-4-yl}-acetic acid ethyl ester; antidiabetic and hypoglycemic agent; non-insulin dependent diabetis, obesity, impaired glucose tolerance, eating disorder, dyslipidemia, hyperlipidemia, hypertension |
| 06/12/2008 | US20080139560 Ion Channel Modulators |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139555 1-[(4-{[4-(3-amino-6-methylphenyl)piperidyl]methyl}phenyl)sulfonyl]-4; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent |
| 06/12/2008 | US20080139484 Sodium dependent glucose transporter inhibitory activity; normalizing blood sugar levels; diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/12/2008 | US20080138453 Chickpea Extracts As Therapeutic Agents And Foods In The Treatment And Prevention Of Obesity And Non-Insulin-Depenent Diabetes |
| 06/12/2008 | US20080138449 Nutraceutical promoting weight loss or weight maintenance; plant extracts of yohimbine, Evodia rutaecarpia, L-carnitine; Yerba Mate, Black tea, Theobroma cacao, White tea dry leaf extract, Caffeine Anhydrous and White willow Bark |
| 06/12/2008 | US20080138436 Food Supplement Composition Suitable For Promoting Iron Absorption |
| 06/12/2008 | US20080138429 Coated Particles and Pharmaceutical Dosage Forms |
| 06/12/2008 | US20080138364 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138317 Monoglycerides; polyethers; antidiabetic agents; rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, asthma, acute respiratory distress syndrome, chronic obstructive pulmonary disease, and multiple sclerosis |
| 06/12/2008 | US20080138314 Use of il-22 for the treatment of conditions of metabolic disorders |
| 06/12/2008 | DE102006058236A1 Indolizinderivate Indolizine derivatives |
| 06/12/2008 | CA2671749A1 Bicyclic compounds and uses as antidiabetics |
| 06/12/2008 | CA2671699A1 Thienyl-containing glycopyranosyl derivatives as antidiabetics |
| 06/12/2008 | CA2671622A1 Treatment of cachexia |
| 06/12/2008 | CA2671177A1 Mixture and method for reducing cholesterol using hydrophobic microparticles |
| 06/12/2008 | CA2670908A1 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators |
| 06/12/2008 | CA2670902A1 4,5,6,7-tetrahydro-thieno [2,3-c] pyridines as h3 modulators |
| 06/12/2008 | CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | CA2670001A1 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 06/12/2008 | CA2668196A1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 06/12/2008 | CA2664112A1 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 06/11/2008 | EP1930341A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930320A1 Novel fused pyrrole derivative |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930017A1 Composition effective for prevention and treatment of adult disease |
| 06/11/2008 | EP1930014A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930013A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930012A1 Cellooligosaccharide-containing composition |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1929873A1 Food material and food product using the same |
| 06/11/2008 | EP1928874A1 Heterobicyclic compounds as glucokinase activators |
| 06/11/2008 | EP1928859A1 Pyrazole derivates as cannabinoid receptor modulators |
| 06/11/2008 | EP1928840A1 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta-hydroxysteroid dehydrogenase |
| 06/11/2008 | EP1928824A1 Process for annealing amorphous atorvastatin |
| 06/11/2008 | EP1928594A2 Method for production of single- and multi-layer microcapsules |
| 06/11/2008 | EP1928504A1 Liver-directed gene therapy |
| 06/11/2008 | EP1928480A2 Methods for managing adipocyte fat accumulation |
| 06/11/2008 | EP1928476A1 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 06/11/2008 | EP1928473A1 Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia |
| 06/11/2008 | EP1928463A2 Method of using potassium channel inhibiting compounds |
| 06/11/2008 | EP1928455A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/11/2008 | EP1928425A1 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 06/11/2008 | EP1928349A2 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 06/11/2008 | EP1603908B1 Quinazoline derivatives as tgf-beta inhibitors |
| 06/11/2008 | EP1532150B1 Novel purine derivatives, production and use thereof as medicaments |
| 06/11/2008 | EP1497293B1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1392846B1 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 06/11/2008 | EP1372621B1 Novel use of tyrosine kinase frk inhibitor |
| 06/11/2008 | EP1239885B1 Interventions to mimic the effects of calorie restriction |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | CN101198614A Thienopyrimidine derivative |
| 06/11/2008 | CN101198598A Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 06/11/2008 | CN101198582A Polymorphic crystal of 4'-{2-[ (1s, 2r) - 2- hydroxy -2- (4-hydroxyphenyl) -1- methylethylamino] ethoxy} - 3 - isopropyl-3', 5' -dimethylbiphenyl - 4 - carboxylic acid hydrochloride |
| 06/11/2008 | CN101198349A Use of leptin for the prevention of excess body weight and composition containing leptin |
| 06/11/2008 | CN101198338A Anti-hypercholesterolemic compounds |
| 06/11/2008 | CN101198326A Combined pharmaceutical preparation for treatment of type 2 diabetes |